Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...

New Zealand Cricket will invest in a new franchise that will join Major League Cricket ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the U.S. Food and Drug Administration (FDA) has ...

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular ...

Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

In the Phase III SELECT-GCA trial, Rinvoq (upadacitinib) 15 mg with a 26-week glucocorticoid taper significantly improved ...

SPRINGFIELD, Ill. (AP) — Democratic Sen. Dick Durbin of Illinois said Wednesday that he will not seek reelection in 2026, ...

Good morning, Chicago. When Carrie Mangoubi sends her young children off to school, she often worries about their safety. At least once a week, her deeply ingrained fear and uncertainty of shootings ...